Literature DB >> 19366492

Humoral immunity to respiratory syncytial virus in young and elderly adults.

C Terrosi1, G Di Genova, B Martorelli, M Valentini, M G Cusi.   

Abstract

Respiratory syncytial virus (RSV) has been demonstrated to cause substantial disease in elderly and immunocompromised subjects. The relationship of serum antibody to RSV infection and the risk of infection in elderly subjects is controversial, thus we evaluated the presence of neutralizing antibodies to RSV in healthy people of different age groups and the correlation with viral protection. Baseline blood samples from 197 subjects aged 20-80 years were analysed for the presence of anti-RSV antibodies either by indirect immunofluorescence and microneutralization test. The percentage of people who had neutralizing antibodies to RSV was significantly higher (P=0.001) in the youngest group (92.51%) compared to the frail group (36.21%). The RSV antibody level tends to wane in some older people; this factor could determine proneness to RSV re-infections in the elderly who are at a greater risk of developing severe respiratory disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19366492     DOI: 10.1017/S0950268809002593

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  11 in total

1.  Effects of aging on the adaptive immune response to respiratory virus infections.

Authors:  Ross B Fulton; Steven M Varga
Journal:  Aging health       Date:  2009-12-01

2.  Utilization of serologic assays to support efficacy of vaccines in nonclinical and clinical trials: meeting at the crossroads.

Authors:  Dace V Madore; Bruce D Meade; Fran Rubin; Carolyn Deal; Freyja Lynn
Journal:  Vaccine       Date:  2010-05-12       Impact factor: 3.641

3.  Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.

Authors:  Teun Guichelaar; Jeroen Hoeboer; Myra N Widjojoatmodjo; Sylvia S N Reemers; Cécile A C M van Els; Rob Otten; Yvonne van Remmerden; Jolande Boes; Willem Luytjes
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

Review 4.  Respiratory syncytial virus infections in the adult asthmatic--mechanisms of host susceptibility and viral subversion.

Authors:  Blair D Westerly; R Stokes Peebles
Journal:  Immunol Allergy Clin North Am       Date:  2010-09-22       Impact factor: 3.479

5.  A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas.

Authors:  Brittani N Blunck; Letisha Aideyan; Xunyan Ye; Vasanthi Avadhanula; Laura Ferlic-Stark; Lynn Zechiedrich; Brian E Gilbert; Pedro A Piedra
Journal:  Vaccine       Date:  2021-01-26       Impact factor: 3.641

6.  Seroprevalence of human respiratory syncytial virus and human metapneumovirus in healthy population analyzed by recombinant fusion protein-based enzyme linked immunosorbent assay.

Authors:  Patricia Sastre; Tamara Ruiz; Oliver Schildgen; Verena Schildgen; Carmen Vela; Paloma Rueda
Journal:  Virol J       Date:  2012-07-02       Impact factor: 4.099

7.  Respiratory syncytial virus outbreak in the basic military training cAMP of the republic of Korea Air Force.

Authors:  Won-Ju Park; Seok-Ju Yoo; Suk-Ho Lee; Jae-Woo Chung; Keun-Ho Jang; Jai-Dong Moon
Journal:  J Prev Med Public Health       Date:  2015-01-14

8.  RSV and HMPV seroprevalence in Tuscany (Italy) and North-Rhine Westfalia (Germany) in the winter season 2009/2010.

Authors:  Maria G Cusi; Chiara Terrosi; Michael Kleines; Oliver Schildgen
Journal:  Influenza Other Respir Viruses       Date:  2011-04-18       Impact factor: 4.380

9.  Role of neutralizing antibodies in adults with community-acquired pneumonia by respiratory syncytial virus.

Authors:  Vivian Luchsinger; Pedro A Piedra; Mauricio Ruiz; Enna Zunino; María Angélica Martínez; Clarisse Machado; Rodrigo Fasce; María Teresa Ulloa; Maria Cristina Fink; Pamela Lara; Luis F Avendaño
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

Review 10.  Low zinc status: a new risk factor for pneumonia in the elderly?

Authors:  Junaidah B Barnett; Davidson H Hamer; Simin N Meydani
Journal:  Nutr Rev       Date:  2010-01       Impact factor: 7.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.